Molecular mechanisms of coxsackievirus persistence in chronic inflammatory myopathy: viral RNA persists through formation of a double-stranded complex without associated genomic mutations or evolution
about
The role of viral persistence in flavivirus biologyMolecular mimicry, bystander activation, or viral persistence: infections and autoimmune disease.The role of enterovirus in chronic fatigue syndromeNeurotropic Enterovirus Infections in the Central Nervous SystemCell-free transmission of human adenovirus by passive mass transfer in cell culture simulated in a computer model.5'-Terminal deletions occur in coxsackievirus B3 during replication in murine hearts and cardiac myocyte cultures and correlate with encapsidation of negative-strand viral RNA.Herpes simplex virus-induced keratitis: evaluation of the role of molecular mimicry in lesion pathogenesis.Activation of NF-kappaB by double-stranded RNA (dsRNA) in the absence of protein kinase R and RNase L demonstrates the existence of two separate dsRNA-triggered antiviral programsCoxsackievirus B3 replication is reduced by inhibition of the extracellular signal-regulated kinase (ERK) signaling pathway.Contribution of protein p40 to hypovirus-mediated modulation of fungal host phenotype and viral RNA accumulationType B coxsackieviruses and their interactions with the innate and adaptive immune systems.Enterovirus infections of the central nervous system.Exogenous interleukin-12 protects against lethal infection with coxsackievirus B4.Intricacies of cardiac damage in coxsackievirus B3 infection: implications for therapy.Type 1 diabetes is associated with enterovirus infection in gut mucosaCoxsackievirus B3 and the neonatal CNS: the roles of stem cells, developing neurons, and apoptosis in infection, viral dissemination, and disease.Retrograde axonal transport: a major transmission route of enterovirus 71 in mice.Recent progress in understanding coxsackievirus replication, dissemination, and pathogenesis.Coxsackievirus B3 mutator strains are attenuated in vivo.Interactions between multiple genetic determinants in the 5' UTR and VP1 capsid control pathogenesis of chronic post-viral myopathy caused by coxsackievirus B1Human enterovirus species B in ileocecal Crohn's diseaseEnterovirus infection of human islets of Langerhans affects β-cell function resulting in disintegrated islets, decreased glucose stimulated insulin secretion and loss of Golgi structureHuman astrocytic cells support persistent coxsackievirus B3 infection.Viral persistence and chronic immunopathology in the adult central nervous system following Coxsackievirus infection during the neonatal period.5' terminal deletions in the genome of a coxsackievirus B2 strain occurred naturally in human heart.Cell cycle status affects coxsackievirus replication, persistence, and reactivation in vitroPersistence of Coxsackievirus B4 in pancreatic ductal-like cells results in cellular and viral changes.Coxsackievirus B3 proteins directionally complement each other to downregulate surface major histocompatibility complex class I.Quantitative genomic and antigenomic enterovirus RNA detection in explanted heart tissue samples from patients with end-stage idiopathic dilated cardiomyopathy.
P2860
Q22809893-E8B0FF43-5A6B-405A-A732-EE70FCB1FA47Q24537348-DA17D028-EF70-41B7-A839-1AE6E8D1D453Q24672347-AF074EB5-510C-4771-95AE-D0CA7DBBA6FDQ26776541-6B96F948-1C3B-4CE8-98B3-4437B4808E59Q30525107-E27EB066-3755-452E-B151-8C51E402A1C9Q33788804-ED17CD6B-4173-4FCF-B26C-19A620BE076AQ33837835-9AA26D2B-163E-498E-BE3B-CA81D138D5F0Q33975105-62F5092B-1417-4116-B22B-26602465F3F6Q34333784-23FA4161-B921-419F-A9D5-3C6948863A35Q34343627-9463C19B-BEEC-440D-85AE-D3CE71575904Q34608956-1B9FC13D-73D7-4157-9ED3-F6D76ACF7E57Q34697319-85DAF1E6-4190-4410-BB6B-8ED1CE310263Q35155018-B50450E8-44FB-44D8-ABC0-B9944552807DQ35483420-D207504A-598E-4A44-8471-0654C136B1CBQ35766884-31408D73-61FD-471D-8FC5-EF40BCBF17BCQ35792228-E7A88226-DBE8-4DF5-BFAD-FBE5AB11B6F4Q35948100-A66D8301-DA52-43C9-BCF1-09EF054C09BFQ36052773-E958DD9C-77B5-4570-B04E-A0C335C9FEA4Q36187182-B0DBF14B-9031-4759-B4C4-4C097E4437FFQ36600425-6E5BEF5E-2BE6-4DFF-BBC4-2B8F43AA608DQ36968335-97707AF1-ECC0-401F-9C40-9948A47C4A3EQ37177400-DEB110E4-DF5A-464E-A90A-B67A272A5AB9Q37254324-60E4C869-71E0-4728-8CC5-342CF15BD1D6Q37333951-E9E8C8CC-EBCA-41CA-A9DA-68ADCF7FCE6CQ39601052-398D7FE4-3592-4F4E-9BA4-9708328C48F8Q39752763-4E0F1CAA-73F7-4CF1-A19C-9D2CE02E9129Q40361991-6E84A8BF-5321-4922-BED2-52B0B46E6B76Q42431804-CD2D4F1B-9DC5-47D4-B97A-21EB76E6961DQ42691275-A1B76E33-E1F8-4F90-9460-66F9E590628E
P2860
Molecular mechanisms of coxsackievirus persistence in chronic inflammatory myopathy: viral RNA persists through formation of a double-stranded complex without associated genomic mutations or evolution
description
1999 nî lūn-bûn
@nan
1999 թուականի Դեկտեմբերին հրատարակուած գիտական յօդուած
@hyw
1999 թվականի դեկտեմբերին հրատարակված գիտական հոդված
@hy
1999年の論文
@ja
1999年論文
@yue
1999年論文
@zh-hant
1999年論文
@zh-hk
1999年論文
@zh-mo
1999年論文
@zh-tw
1999年论文
@wuu
name
Molecular mechanisms of coxsac ...... genomic mutations or evolution
@ast
Molecular mechanisms of coxsac ...... genomic mutations or evolution
@en
type
label
Molecular mechanisms of coxsac ...... genomic mutations or evolution
@ast
Molecular mechanisms of coxsac ...... genomic mutations or evolution
@en
prefLabel
Molecular mechanisms of coxsac ...... genomic mutations or evolution
@ast
Molecular mechanisms of coxsac ...... genomic mutations or evolution
@en
P2860
P1433
P1476
Molecular mechanisms of coxsac ...... genomic mutations or evolution
@en
P2093
P2860
P304
10113-10121
P577
1999-12-01T00:00:00Z